Forecasts from a variety of modeling teams are combined to provide a picture of what may happen in the future.
COVID-19 vaccines have undergone the most intensive safety monitoring in U.S. history. Learn about clinical trials and different safety monitoring systems.
Forecasts show national and state level cumulative reported and predicted deaths since the beginning of the pandemic. CDC is working with partners to bring together weekly COVID-19 forecasts in one place.
CDC COVID Data Tracker - Cases and Deaths by State
If you are sick with COVID-19 or suspect you are infected with the virus that causes COVID-19, you should take steps to help prevent the disease from spreading to people in your home and community.
COVID-19 vaccines are safe and effective. Millions of people in the United States have received COVID-19 vaccines, and these vaccines will undergo the most intensive safety monitoring in U.S. history. CDC recommends you get a COVID-19 vaccine as soon as you are eligible. Adverse events described on this page have been reported to the Vaccine Adverse Event Reporting System (VAERS).
CDC reports COVID-19 vaccination data online on COVID Data Tracker and in vaccination datasets.
Information on COVID-19 vaccination data reported in CDC's COVID Data Tracker.
Find links to resources for clinicians caring for patients with a suspected or confirmed infection caused by coronavirus disease 2019 (COVID-19).
Clinicians, learn how you can best care for your patients with a confirmed infection caused by novel coronavirus 2019 (COVID-19).
People of Any Age with Underlying Medical Conditions
People Who Are Immunocompromised
Learn COVID-19 operational considerations to implement immunization services in non-US countries with low or middle incomes.
A review of the week's key data from CDC's COVID Data Tracker, narrative interpretations, and visualizations.
CDC's multiplex assay simultaneously detects influenza A virus, influenza B virus, and SARS-CoV-2, the virus that causes COVID-19.
This page provides information on types of COVID-19 Tests and Supplies for laboratory personnel. This page also provides answers to FAQ's that pertain to testing types and supplies.
Strategy defines CDC program priorities & guides development of criteria for monitoring & evaluating impact for CDC's global response to the COVID-19 pandemic.
This page includes interim guidance and resources for laboratory professionals working with specimens from persons under investigation (PUI) for coronavirus disease 2019 (COVID-19).
Risk of COVID-19 hospitalization and death by race/ethnicity
Risk of COVID-19 hospitalization and death by age group
CDC is using both new and existing information technology (IT) systems to rapidly collect reliable data about how many doses of COVID-19 vaccines have been delivered (distribution) and how many people have been vaccinated with those doses (administration)
Systemic health and social inequities have put people from racial and ethnic minority groups at increased risk from COVID-19. Take steps to reduce health disparities.
CDC recommends that moderately or severely immunocompromised people receive an additional dose of mRNA COVID-19 vaccine at least four weeks after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.
people who are up to date with their vaccines are well protected from serious illness or other health outcomes.
Pregnant people need to take steps to protect themselves and stay healthy during the COVID-19.
Schools & Childcare: Guidance for School Settings
Healthcare personnel who are pregnant or breastfeeding may get vaccinated for COVID-19, but there are many considerations that go into that decision.
Clinicians, learn about considerations for people diagnosed with COVID-19 who are pregnant and recently pregnant, children, and people who are immunocompromised, people with MIS, and people with post-COVID-19 conditions.
This page provides a broad overview of therapies that are currently recommended for COVID-19 treatment. The FDA can issue emergency use authorizations (EUAs) to allow healthcare providers to use products that are not yet approved, or are approved for other uses, to treat patients with COVID-19 if certain legal requirements are met. The National Institutes of Health (NIH) has developed and regularly updates Treatment Guidelines to help guide healthcare providers caring patients with COVID-19. Any treatments that are used for COVID-19 should be under the care of a healthcare provider.
Clinicians, learn about the clinical presentations, including uncommon presentations, and transmission of COVID-19 when caring for patients with a confirmed COVID-19.
Clinicians, learn about reinfection when caring for patients with a confirmed COVID-19.
Clinicians, learn about the clinical course of COVID-19, including the progression, managements, and treatment, when caring for patients with a confirmed COVID-19.